References
Pocock SJ, Ariti CA, Collier TJ, et al. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. 2012;33:176–82.
Ferreira JP, Jhund PS, Duarte K, et al. Use Win Ratio Cardiovasc Trials Heart Fail. 2020;8:441–50.
Oakes D. On the win-ratio statistic in clinical trials with multiple types of events. Biometrika. 2016;103:742–5.
Food US, Administration D, E9(R1.) Statistical Principles for Clinical Trials: Addendum: Estimands and Sensitivity Analysis in Clinical Trials, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e9r1-statistical-principles-clinical-trials-addendum-estimands-and-sensitivity-analysis-clinical.
Funding
There are no sources of study funding.
Author information
Authors and Affiliations
Contributions
HL conceived of the paper and wrote the first draft. WCC did the computation and contributed to the development and preparation of the article. NL, RT and YZ contributed to the development and preparation of the article. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
There are no financial interests in relation to the work described.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Li, H., Chen, WC., Lu, N. et al. The Elusiveness of the Win Ratio Parameter in the Presence of Missing Data. Ther Innov Regul Sci 58, 431–432 (2024). https://doi.org/10.1007/s43441-024-00645-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43441-024-00645-2